AbbVie Inc - Total Other Income Expense Net

AbbVie Inc's Fiscal Year is From January To December - All Figures are in USD, Billions.

The item "Total-Other-Income-Expense-Net" stands at -11.34 Billion United States Dollars for the trailing twelve months (TTM) period ending 09/30/2025, the lowest value at least since 03/31/2012, the period currently displayed.

AbbVie Inc's third quarter result of -4.18 Billion USD for the item "Total Other Income Expense Net" represents an increase of 3.04 percent compared to it's second quarter result.

Also, AbbVie Inc's third quarter result of -4.18 Billion USD for the item "Total Other Income Expense Net" represents a decrease of -139.10 percent compared to it's third quarter result of last year.

Looking again at the trailing twelve months series (TTM), AbbVie Inc's third quarter result of -11.34 Billion USD for the item "Total Other Income Expense Net" represents a decrease of -27.28 percent compared to it's second quarter result.


Regarding the One-Year-Change of the series, the current value constitutes an decrease of -4.71 Billion United States Dollars compared to the value the year prior.
The 1 year change is -4.71 Billion United States Dollars.
The 3 year change is -8.43 Billion United States Dollars.
The 5 year change is -7.75 Billion United States Dollars.
The 10 year change is -10.01 Billion United States Dollars.

The Serie's long term average value is -3.26 Billion United States Dollars. It's latest available value, on 09/30/2025, is -8.08 Billion United States Dollars lower, compared to it's long term average value.
The Serie's change in United States Dollars from it's minimum value, on 09/30/2025, to it's latest available value, on 09/30/2025, is +0.0 Billion.
The Serie's change in United States Dollars from it's maximum value, on 12/31/2011, to it's latest available value, on 09/30/2025, is -11.38 Billion.